These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
500 related items for PubMed ID: 23798013
1. The neuronal ceroid-lipofuscinoses. Bennett MJ, Rakheja D. Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013 [Abstract] [Full Text] [Related]
6. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis]. Taschner PE, Losekoot M, Breuning MH, Hofman I, van Diggelen OP. Ned Tijdschr Geneeskd; 2005 Feb 05; 149(6):300-3. PubMed ID: 15730038 [Abstract] [Full Text] [Related]
7. The molecular genetic basis of the neuronal ceroid lipofuscinoses. Gardiner RM. Neurol Sci; 2000 Feb 05; 21(3 Suppl):S15-9. PubMed ID: 11073223 [Abstract] [Full Text] [Related]
8. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Mole SE, Williams RE. ; 1993 Feb 05. PubMed ID: 20301601 [Abstract] [Full Text] [Related]
10. Neuronal ceroid lipofuscinoses caused by defects in soluble lysosomal enzymes (CLN1 and CLN2). Hofmann SL, Atashband A, Cho SK, Das AK, Gupta P, Lu JY. Curr Mol Med; 2002 Aug 05; 2(5):423-37. PubMed ID: 12125808 [Abstract] [Full Text] [Related]
16. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population. Teixeira C, Guimarães A, Bessa C, Ferreira MJ, Lopes L, Pinto E, Pinto R, Boustany RM, Sá Miranda MC, Ribeiro MG. J Neurol; 2003 Jun 05; 250(6):661-7. PubMed ID: 12796825 [Abstract] [Full Text] [Related]
17. Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers. Sleat DE, Tannous A, Sohar I, Wiseman JA, Zheng H, Qian M, Zhao C, Xin W, Barone R, Sims KB, Moore DF, Lobel P. J Proteome Res; 2017 Oct 06; 16(10):3787-3804. PubMed ID: 28792770 [Abstract] [Full Text] [Related]
18. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses. Kida E, Golabek AA, Wisniewski KE. Adv Genet; 2001 Oct 06; 45():35-68. PubMed ID: 11332776 [Abstract] [Full Text] [Related]
19. Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses. Sima N, Li R, Huang W, Xu M, Beers J, Zou J, Titus S, Ottinger EA, Marugan JJ, Xie X, Zheng W. Orphanet J Rare Dis; 2018 Apr 10; 13(1):54. PubMed ID: 29631617 [Abstract] [Full Text] [Related]